Literature DB >> 10219778

Bethlem myopathy: a slowly progressive congenital muscular dystrophy with contractures.

G J Jöbsis1, J M Boers, P G Barth, M de Visser.   

Abstract

Bethlem myopathy is an early-onset benign autosomal dominant myopathy with contractures caused by mutations in collagen type VI genes. It has been reported that onset occurs in early childhood. We investigated the natural course of Bethlem myopathy in five previously published kindreds and two novel pedigrees, with particular attention to the mode of onset in 23 children and the progression of weakness in 36 adult patients. Our analysis shows that nearly all children exhibit weakness or contractures during the first 2 years of life. Early features include diminished foetal movements, neonatal hypotonia and congenital contractures which are of a dynamic nature during childhood. The course of Bethlem myopathy in adult patients is less benign than previously thought. Due to slow but ongoing progression, more than two-thirds of patients over 50 years of age use a wheelchair.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219778     DOI: 10.1093/brain/122.4.649

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  35 in total

1.  Structure of a collagen VI α3 chain VWA domain array: adaptability and functional implications of myopathy causing mutations.

Authors:  Herimela Solomon-Degefa; Jan M Gebauer; Cy M Jeffries; Carolin D Freiburg; Patrick Meckelburg; Louise E Bird; Ulrich Baumann; Dmitri I Svergun; Raymond J Owens; Jörn M Werner; Elmar Behrmann; Mats Paulsson; Raimund Wagener
Journal:  J Biol Chem       Date:  2020-07-21       Impact factor: 5.157

Review 2.  The collagenopathies: review of clinical phenotypes and molecular correlations.

Authors:  Rebekah Jobling; Rohan D'Souza; Naomi Baker; Irene Lara-Corrales; Roberto Mendoza-Londono; Lucie Dupuis; Ravi Savarirayan; L Ala-Kokko; Peter Kannu
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

Review 3.  The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy.

Authors:  Carsten G Bönnemann
Journal:  Handb Clin Neurol       Date:  2011

4.  A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16.

Authors:  Te-Cheng Pan; Rui-Zhu Zhang; Machiko Arita; Sasha Bogdanovich; Sheila M Adams; Sudheer Kumar Gara; Raimund Wagener; Tejvior S Khurana; David E Birk; Mon-Li Chu
Journal:  J Biol Chem       Date:  2014-02-22       Impact factor: 5.157

Review 5.  Collagen VI related muscle disorders.

Authors:  A K Lampe; K M D Bushby
Journal:  J Med Genet       Date:  2005-09       Impact factor: 6.318

6.  New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype.

Authors:  Te-Cheng Pan; Rui-Zhu Zhang; Dominick G Sudano; Suely K Marie; Carsten G Bönnemann; Mon-Li Chu
Journal:  Am J Hum Genet       Date:  2003-07-01       Impact factor: 11.025

7.  Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity.

Authors:  Rishika A Pace; Rachel A Peat; Naomi L Baker; Laura Zamurs; Matthias Mörgelin; Melita Irving; Naomi E Adams; John F Bateman; David Mowat; Nicholas J C Smith; Phillipa J Lamont; Steven A Moore; Katherine D Mathews; Kathryn N North; Shireen R Lamandé
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

8.  Mechanical and electrophysiological properties of the sarcolemma of muscle fibers in two murine models of muscle dystrophy: col6a1-/- and mdx.

Authors:  M Canato; M Dal Maschio; F Sbrana; R Raiteri; C Reggiani; S Vassanelli; A Megighian
Journal:  J Biomed Biotechnol       Date:  2010-04-08

9.  Zebrafish models of collagen VI-related myopathies.

Authors:  W R Telfer; A S Busta; C G Bonnemann; E L Feldman; J J Dowling
Journal:  Hum Mol Genet       Date:  2010-03-25       Impact factor: 6.150

10.  Autosomal recessive inheritance of classic Bethlem myopathy.

Authors:  A Reghan Foley; Ying Hu; Yaqun Zou; Alexandra Columbus; John Shoffner; Diane M Dunn; Robert B Weiss; Carsten G Bönnemann
Journal:  Neuromuscul Disord       Date:  2009-11-01       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.